Hematology

54 Expert Conversations

54 Expert Conversations
Multiple myeloma. FAQ: Immunization, Vitamin D and bone health, quality of life. 12
Multiple myeloma. Patient’s story: elderly woman and ‘last hope’ CAR T-cell therapy. 13
Multiple myeloma and gene expression profiling. Intraclonal heterogeneity. 4
Multiple myeloma. Message of hope for cancer treatment and for life. 14
Multiple myeloma and bone marrow microenvironment. ‘Seed and soil’ concept in cancer progression. 3
Autologous stem cell transplantation in multiple myeloma. 6
Dr. Nikhil Munshi. Multiple myeloma expert. Biography. 0
Future in multiple myeloma treatment. When will it be a ‘curable disease’? 11
Multiple myeloma. Progress and challenges of treatment. 1
Multiple myeloma. Minimal Residual Disease evaluation. Prognosis. 9
Multiple myeloma. Risk stratification criteria to select the best treatment for each patient. 5
Multiple myeloma. Genetic changes. MGUS. Smoldering myeloma. 2
How to select drug combinations for multiple myeloma treatment? 7
Chimeric antigen receptor T-cell therapy in multiple myeloma. CAR T-cell immunotherapy. 8
Castleman Disease. Subtypes and treatment options. 10
No doctor should be offended if a patient seeks expert opinion!
Deep Vein Thrombosis controversies. Treatment of blood clots that are below or above knee
Hypertension treatment success and failure. Top cardiologist discusses two clinical cases. 11
Blood clots below and above the knee. How to treat deep venous thrombosis? 13
How is DVT diagnosed? How to find blood clots in legs? 12
Pulmonary Arterial Hypertension therapy with anticoagulants is outdated. 4
Gene therapy in leukemia. Advanced treatments in hematology. 7
Causes of blood clots. Deep Venous Thrombosis. 6
How to find cause of anemia? Two blood tests to diagnose anemia. 5
Myeloproliferative disorder. Diagnosis and treatment. 4
Myelodysplastic syndrome. Treatment and prognosis. 3
Treatment of Hemophilia. Acquired hemophilia therapy. 2
Treatment of Blood Diseases. Hematology. 1
Intracerebral Hemorrhage. Treatment and prognosis of brain bleeding. 8
MGUS and acquired 
von Willibrand syndrome. 12
Atrial fibrillation in elderly patients. Thrombosis vs. bleeding risk. 7
Direct oral anticoagulants or vitamin K antagonists? When to use? 6
Deep vein thrombosis and cancer risk. Heparin and aspirin in DVT. 5
Blood clots risk and mutations. Do a genetic test or not? 4. [Parts 1 and 2]
Hemophilia. New treatment options. Emicizumab.
Gene therapy. 3 [Part 1 and 2]
Von Willebrand disease. New treatment options. MGUS. Acquired VWD. 2
Chronic liver disease. How to use laboratory tests correctly? 1
VITT.
vaccine-induced thrombotic thrombocytopenia and COVID-19 vaccination. 11. [Parts 1 and 2]
New oral anticoagulants for patients after heart valve surgery? NOACs or coumadin? 4
Mechanical or animal tissue heart valve for mitral or aortic valve replacement? Stented or stentless heart valve? 3
Recently viewed

Explore Masterclasses by topic